Skip to main content
OpenTrials

Clinical trial condition

Herpes Simplex

Explore clinical trials studying Herpes Simplex. Study availability and eligibility vary by location and protocol.

133 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Herpes Simplex trial results

Completed

Evaluating New Formulation of Therapeutic HSV-2 Vaccine

NCT02515175

Conditions
Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +18 more
Locations
  • University of Alabama-Birmingham Birmingham, Alabama, United States
  • Medical Center for Clinical Research San Diego, California, United States
  • Quest Clinical Research San Francisco, California, United States
  • The Fenway Institute Boston, Massachusetts, United States
View Trial Details
Completed

VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.

NCT00116844

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • GSK Investigational Site Carmichael, California, United States
  • GSK Investigational Site Davis, California, United States
  • GSK Investigational Site Riverside, California, United States
  • GSK Investigational Site Sacramento, California, United States
View all 17 locations
View Trial Details
Completed

Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity

NCT02910284

Conditions
Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +18 more
Locations
  • University of Alabama - Birmingham Birmingham, Alabama, United States
  • Medical Center for Clinical Research San Diego, California, United States
  • Quest Clinical Research San Francisco, California, United States
  • University of Illinois - Chicago Chicago, Illinois, United States
View all 13 locations
View Trial Details
Completed

Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine

NCT02114060

Conditions
DNA Virus Infections, Genital Herpes Simplex Type 2, Herpes Simplex, +7 more
Locations
  • University of Alabama Vaccine Research Unit Birmingham, Alabama, United States
  • Medical Center for Clinical Research San Diego, California, United States
  • Quest Clinical Research San Francisco, California, United States
  • University of Illinois Department of Medicine Chicago, Illinois, United States
View all 16 locations
View Trial Details
Completed

Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study

NCT02300142

Conditions
DNA Virus Infections, Genital Herpes Simplex Type 2, Herpes Simplex, +7 more
Locations
  • University of Alabama Vaccine Research Unit Birmingham, Alabama, United States
  • Medical Center for Clinical Research San Diego, California, United States
  • Quest Clinical Research San Francisco, California, United States
  • University of Illinois Department of Medicine Chicago, Illinois, United States
View all 16 locations
View Trial Details
Completed

A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And Children

NCT00297206

Conditions
DNA Virus Infections, Herpes Simplex, Herpesviridae Infections, +6 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site Jacksonville, Florida, United States
View all 13 locations
View Trial Details

Related conditions